300122 智飞生物
已收盘 04-26 15:00:00
资讯
新帖
简况
疫苗龙头,没了2800亿
格隆汇 · 04-25 20:25
疫苗龙头,没了2800亿
疫苗江湖风起云涌,智飞生物“一哥”地位难保
市场资讯 · 04-25 20:06
疫苗江湖风起云涌,智飞生物“一哥”地位难保
智飞生物(300122)4月23日主力资金净卖出1.36亿元
证券之星 · 04-24
智飞生物(300122)4月23日主力资金净卖出1.36亿元
一季度净利润同比下降!智飞生物跌近15%,公司回应
21世纪经济报道 · 04-23
一季度净利润同比下降!智飞生物跌近15%,公司回应
智飞生物低开低走盘中跌超14% 一季度净利跌近三成
市场资讯 · 04-23
智飞生物低开低走盘中跌超14% 一季度净利跌近三成
智飞生物一季度净利跌近三成,去年九价HPV疫苗批签发量增超1.3倍
澎湃新闻 · 04-23
智飞生物一季度净利跌近三成,去年九价HPV疫苗批签发量增超1.3倍
图解智飞生物一季报:第一季度单季净利润同比减28.26%
证券之星 · 04-23
图解智飞生物一季报:第一季度单季净利润同比减28.26%
图解智飞生物年报:第四季度单季净利润同比减20.31%
证券之星 · 04-23
图解智飞生物年报:第四季度单季净利润同比减20.31%
智飞生物(300122.SZ)发布一季度业绩,净利润14.58亿元,同比下降28.26%
智通财经 · 04-22
智飞生物(300122.SZ)发布一季度业绩,净利润14.58亿元,同比下降28.26%
智飞生物最新公告:一季度净利润14.58亿元 同比下降28.26%
证券之星 · 04-22
智飞生物最新公告:一季度净利润14.58亿元 同比下降28.26%
智飞生物最新公告:2023年归母净利润80.7亿元 同比增长7.04%
证券之星 · 04-22
智飞生物最新公告:2023年归母净利润80.7亿元 同比增长7.04%
智飞生物:2023年归母净利润80.7亿元,同比增长7.04%
港股那点事 · 04-22
智飞生物:2023年归母净利润80.7亿元,同比增长7.04%
智飞生物(300122.SZ)完成回购 累计耗资3亿元回购621.03万股
智通财经网 · 03-28
智飞生物(300122.SZ)完成回购 累计耗资3亿元回购621.03万股
智飞生物(300122.SZ)首次回购131.67万股 耗资6584.26万元
智通财经网 · 03-18
智飞生物(300122.SZ)首次回购131.67万股 耗资6584.26万元
山河药辅与智飞生物合作开发注射产品?公司回应
中证报 · 03-01
山河药辅与智飞生物合作开发注射产品?公司回应
智飞生物:拟以3亿元-5亿元回购股份
港股那点事 · 02-22
智飞生物:拟以3亿元-5亿元回购股份
智飞生物“减肥药”新故事:业绩增长毛利率却下滑,市值蒸发超2000亿
市场资讯 · 2023-12-20
智飞生物“减肥药”新故事:业绩增长毛利率却下滑,市值蒸发超2000亿
股价一度跳水下跌超9% 智飞生物:经营情况一切正常 市场销售良好
证券时报 · 2023-12-15
股价一度跳水下跌超9% 智飞生物:经营情况一切正常 市场销售良好
研发投入猛增,研发成果井喷,业绩高基数高增长:1600亿智飞生物,自研与国际化将成最大看点!
市场资讯 · 2023-11-30
研发投入猛增,研发成果井喷,业绩高基数高增长:1600亿智飞生物,自研与国际化将成最大看点!
智飞生物跨界向实控人收购减肥药卷入“蓝海” 自主产品收入仅占3.52%市值两年半蒸发2100亿
市场资讯 · 2023-11-27
智飞生物跨界向实控人收购减肥药卷入“蓝海” 自主产品收入仅占3.52%市值两年半蒸发2100亿
加载更多
公司概况
公司名称:
重庆智飞生物制品股份有限公司
所属行业:
医药制造业
上市日期:
2010-09-28
主营业务:
重庆智飞生物制品股份有限公司是一家从事疫苗、生物制品的研发、生产和销售的公司;公司的主要产品包括预防流脑、宫颈癌、肺炎、轮状病毒等传染病的疫苗产品,也涵盖提供结核感染诊断、预防、治疗有效解决方案的药品。公司自成立以来,一贯注重研发与技术创新,通过十余年稳步增长的研发投入和持续深入的研发活动,形成了行业较领先的研发技术能力,并为公司可持续发展提供了技术根基。先后参与了科技部“863计划”,“现代医学技术”项目,科技部重大新药创制,国家新药创制重大专项等20余项国家级,省部级项目。
发行价格:
37.98
{"stockData":{"symbol":"300122","market":"SZ","secType":"STK","nameCN":"智飞生物","latestPrice":34.83,"timestamp":1714114995000,"preClose":34.21,"halted":0,"volume":27788335,"delay":0,"floatShares":1414000000,"shares":2394000000,"eps":3.1313,"marketStatus":"已收盘","marketStatusCode":5,"change":0.62,"latestTime":"04-26 15:00:00","open":34.18,"high":34.88,"low":33.81,"amount":957000000,"amplitude":0.0313,"askPrice":34.84,"askSize":585,"bidPrice":34.83,"bidSize":479,"shortable":0,"etf":0,"ttmEps":3.1313,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":34.21,"symbolType":"stock","openAndCloseTimeList":[[1714095000000,1714102200000],[1714107600000,1714114800000]],"highLimit":37.63,"lowLimit":30.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2393789747,"pbRate":2.51,"roa":"--","roe":"4.52%","epsLYR":3.3624,"committee":-0.32231,"marketValue":83376000000,"floatMarketCap":49260000000,"peRate":11.123176,"changeRate":0.0181,"turnoverRate":0.0196,"status":0},"requestUrl":"/m/hq/s/300122","defaultTab":"news","newsList":[{"id":"2430021324","title":"疫苗龙头,没了2800亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2430021324","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2430021324?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:25","pubTimestamp":1714047925,"startTime":"0","endTime":"0","summary":"高光不再","market":"sg","thumbnail":"https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723988","is_publish_highlight":false,"gpt_icon":0},{"id":"2430402125","title":"疫苗江湖风起云涌,智飞生物“一哥”地位难保","url":"https://stock-news.laohu8.com/highlight/detail?id=2430402125","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2430402125?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:06","pubTimestamp":1714046760,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 在“疫苗一哥”智飞生物发布2023年年报后,其股价便连续下跌,有市场人士则将其下跌的股价,与其高度依赖的国外供应商和逐渐显露的业绩颓势联系在一起。 近几年来,疫苗市场风云变幻,一方面,曾经的“爆款”九价HPV疫苗不再一针难求;另一方面,国产九价HPV疫苗各种好消息不断传出,引来不少机构对其上市进程的高度关注。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-04-25/doc-inataefs7380124.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-04-25/doc-inataefs7380124.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429178140","title":"智飞生物(300122)4月23日主力资金净卖出1.36亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429178140","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429178140?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:15","pubTimestamp":1713921349,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月23日收盘,智飞生物报收于35.39元,下跌11.99%,换手率5.52%,成交量78.08万手,成交额27.4亿元。近5日资金流向一览见下表:智飞生物融资融券信息显示,融资方面,当日融资买入2.12亿元,融资偿还2.27亿元,融资净偿还1566.35万元。智飞生物主营业务:疫苗、生物制品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400018361.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429158060","title":"一季度净利润同比下降!智飞生物跌近15%,公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2429158060","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2429158060?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:54","pubTimestamp":1713851640,"startTime":"0","endTime":"0","summary":" 南方财经4月23日电,智飞生物 低开后一路走低,截至早盘收盘,跌14.67%,报34.31元。消息面上,智飞生物今年第一季度营业收入113.96亿元,同比增长2%;归母净利润14.58亿元,同比下降28.26%。对于一季度利润下降,智飞生物并未在公告中说明原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-23/doc-inasuzcy8991754.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-23/doc-inasuzcy8991754.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429133892","title":"智飞生物低开低走盘中跌超14% 一季度净利跌近三成","url":"https://stock-news.laohu8.com/highlight/detail?id=2429133892","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429133892?lang=zh_cn&edition=full","pubTime":"2024-04-23 10:23","pubTimestamp":1713838980,"startTime":"0","endTime":"0","summary":" 4月23日消息,智飞生物低开低走,截至发稿,跌14.40%,报34.42元/股,成交额14.33亿元,总市值823.9亿元。 消息面上,4月22日晚间,重庆智飞生物制品股份有限公司发布2023年度业绩报告,全年营业收入约529.18亿元,同比增长38.3%;归母净利润约80.7亿元,同比增加7.04%;归母扣非净利润79.15亿元,同比增长5.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/2024-04-23/doc-inasuqpz0184059.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/2024-04-23/doc-inasuqpz0184059.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429855331","title":"智飞生物一季度净利跌近三成,去年九价HPV疫苗批签发量增超1.3倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2429855331","media":"澎湃新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429855331?lang=zh_cn&edition=full","pubTime":"2024-04-23 07:52","pubTimestamp":1713829920,"startTime":"0","endTime":"0","summary":" “疫苗茅”智飞生物2023年营收净利维持了双增的态势,但今年第一季度的业绩表现不太好。 4月22日晚间,重庆智飞生物制品股份有限公司发布2023年度业绩报告,全年营业收入约529.18亿元,同比增长38.3%;归母净利润约80.7亿元,同比增加7.04%;归母扣非净利润79.15亿元,同比增长5.4%。智飞生物并未在一季报中直接说明原因。从具体产品层面,九价HPV疫苗批签发量暴涨136.16%至3655.08万支,四价HPV疫苗下降26.27%至1034.34万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-23/doc-inasukhc0263939.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-23/doc-inasukhc0263939.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429972659","title":"图解智飞生物一季报:第一季度单季净利润同比减28.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429972659","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429972659?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:49","pubTimestamp":1713808199,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物2024年一季报显示,公司主营收入113.96亿元,同比上升2.0%;归母净利润14.58亿元,同比下降28.26%;扣非净利润14.55亿元,同比下降28.36%;负债率39.02%,财务费用596.36万元,毛利率26.05%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300002281.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429971184","title":"图解智飞生物年报:第四季度单季净利润同比减20.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429971184","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429971184?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:43","pubTimestamp":1713804236,"startTime":"0","endTime":"0","summary":"证券之星消息,智飞生物2023年年报显示,公司主营收入529.18亿元,同比上升38.3%;归母净利润80.7亿元,同比上升7.04%;扣非净利润79.15亿元,同比上升5.4%;其中2023年第四季度,公司单季度主营收入136.46亿元,同比上升30.7%;单季度归母净利润15.4亿元,同比下降20.31%;单季度扣非净利润15.35亿元,同比下降20.03%;负债率37.28%,财务费用4721.82万元,毛利率26.92%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300000716.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429927309","title":"智飞生物(300122.SZ)发布一季度业绩,净利润14.58亿元,同比下降28.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429927309","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429927309?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:25","pubTimestamp":1713795900,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 智飞生物(300122.SZ)发布2024年第一季度报告,公司营业收入113.96亿元,同比增长2.00%;归属于上市公司股东的净利润14.58亿元,同比下降28.26%;归属于上市公司股东的扣除非经常性损益的净利润14.55亿元,同比下降28.36%;基本每股收益0.6090元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107170.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429922703","title":"智飞生物最新公告:一季度净利润14.58亿元 同比下降28.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429922703","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429922703?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:20","pubTimestamp":1713795606,"startTime":"0","endTime":"0","summary":"智飞生物公布2024年一季度报告,报告期营业收入113.96亿元,同比增长2.00%;归属于上市公司股东的净利润14.58亿元,同比下降28.26%;基本每股收益0.6090元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200030367.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429924842","title":"智飞生物最新公告:2023年归母净利润80.7亿元 同比增长7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429924842","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429924842?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:50","pubTimestamp":1713793828,"startTime":"0","endTime":"0","summary":"智飞生物发布2023年年度报告,报告期内,公司实现营业收入529.18亿元,较上年同期增长38.30%;实现归属于上市公司股东的净利润80.70亿元,较上年同期增长7.04%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200029921.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429892247","title":"智飞生物:2023年归母净利润80.7亿元,同比增长7.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429892247","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2429892247?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:48","pubTimestamp":1713793680,"startTime":"0","endTime":"0","summary":"格隆汇4月22日|智飞生物发布2023年年度报告,报告期内,公司实现营业收入529.18亿元,较上年同期增长38.30%;实现归属于上市公司股东的净利润80.70亿元,较上年同期增长7.04%;实现归属于上市公司股东的扣除非经常性损益的净利润79.15亿元,较上年同期增长5.40%。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inastpas9734426.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-22/doc-inastpas9734426.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422994111","title":"智飞生物(300122.SZ)完成回购 累计耗资3亿元回购621.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422994111","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422994111?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:10","pubTimestamp":1711631400,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告,公司股份回购已实施完成,公司累计通过回购专用证券账户以集中竞价交易方式回购公司股份621.03万股,占公司当前总股本的0.26%,成交总金额为3亿元(不含交易费用)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapwvcn5354176.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapwvcn5354176.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420428870","title":"智飞生物(300122.SZ)首次回购131.67万股 耗资6584.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420428870","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2420428870?lang=zh_cn&edition=full","pubTime":"2024-03-18 17:17","pubTimestamp":1710753420,"startTime":"0","endTime":"0","summary":"智飞生物(300122.SZ)公告,2024年3月15日,公司通过回购专用证券账户以集中竞价交易方式首次回购公司股份131.67万股,占公司当前总股本的0.05%,最高成交价为50.34元/股,最低成交价为49.80元/股,成交总金额为人民币6584.26万元(不含交易费用)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantvpn5374408.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantvpn5374408.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2416903610","title":"山河药辅与智飞生物合作开发注射产品?公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2416903610","media":"中证报","top":-1,"share":"https://www.laohu8.com/m/news/2416903610?lang=zh_cn&edition=full","pubTime":"2024-03-01 21:10","pubTimestamp":1709298600,"startTime":"0","endTime":"0","summary":"3月1日,针对“山河药辅与智飞生物合作开发注射产品”的市场传闻,山河药辅证券部工作人员对中国证券报·中证金牛座记者独家表示,公司注射剂辅料还没有经过CDE的关联审评(即药品监督管理局的一致性评价),与客户的合作都停留在样品开发阶段。\n 上述工作人员称,注射剂辅料关联审评没有通过,就不能形成实质性订单,目前还都是样品。下游客户用公司注射剂做试验样品很常见,很多大型药企都是公司的客户。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:王其霖","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/2024-03-01/doc-inakvqye7357816.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/2024-03-01/doc-inakvqye7357816.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413961892","title":"智飞生物:拟以3亿元-5亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2413961892","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2413961892?lang=zh_cn&edition=full","pubTime":"2024-02-22 18:52","pubTimestamp":1708599120,"startTime":"0","endTime":"0","summary":"智飞生物公告,拟以3亿元-5亿元回购股份,回购价格不超过人民币75元/股。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-02-22/doc-inaixiwf1744731.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-02-22/doc-inaixiwf1744731.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2392713635","title":"智飞生物“减肥药”新故事:业绩增长毛利率却下滑,市值蒸发超2000亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2392713635","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2392713635?lang=zh_cn&edition=full","pubTime":"2023-12-20 08:20","pubTimestamp":1703031600,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 《港湾商业观察》廖紫雯。 近日,有着“疫苗茅”之称的智飞生物拟将拥有“司美格鲁肽”的宸安生物收入囊中,业务版图延伸覆盖至糖尿病、肥胖等代谢类疾病领域,版图延伸的另一面,是公司三年来蒸发超2000亿的市值,以及长期围绕着的代理业务“阴影”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2023-12-20/doc-imzyriac8861404.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2023-12-20/doc-imzyriac8861404.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2391065987","title":"股价一度跳水下跌超9% 智飞生物:经营情况一切正常 市场销售良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2391065987","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2391065987?lang=zh_cn&edition=full","pubTime":"2023-12-15 14:48","pubTimestamp":1702622880,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 15日午后,智飞生物股价突然跳水,盘中一度下跌超9%。对此,记者以投资者身份致电智飞生物,其工作人员表示,智飞生物经营情况一切正常,市场销售良好。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:冯体炜","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2023-12-15/doc-imzyaqhu0236717.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2023-12-15/doc-imzyaqhu0236717.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2387141051","title":"研发投入猛增,研发成果井喷,业绩高基数高增长:1600亿智飞生物,自研与国际化将成最大看点!","url":"https://stock-news.laohu8.com/highlight/detail?id=2387141051","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2387141051?lang=zh_cn&edition=full","pubTime":"2023-11-30 18:17","pubTimestamp":1701339420,"startTime":"0","endTime":"0","summary":"切入“减肥药”风口,研发投入猛增,研发成果井喷,业绩高基数高增长:1600亿智飞生物,自研与国际化将成最大看点! 公司目前正处国际化初期阶段,进步空间巨大。 2023年11月22日,智飞生物公告了《股权收购意向协议》,宣布拟收购宸安生物100%的股权。 宸安生物聚焦糖尿病、肥胖等代谢类疾病领域,已有梯次分明的产品管道布局,拥有6款已进入临床研究的候选药物:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2023-11-30/doc-imzwmafq5111703.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2023-11-30/doc-imzwmafq5111703.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2386563973","title":"智飞生物跨界向实控人收购减肥药卷入“蓝海” 自主产品收入仅占3.52%市值两年半蒸发2100亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2386563973","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2386563973?lang=zh_cn&edition=full","pubTime":"2023-11-27 08:25","pubTimestamp":1701044700,"startTime":"0","endTime":"0","summary":" 在代理产品近年增长遇瓶颈的压力下,蒋仁生推动疫苗巨头智飞生物跨界,跳入目前看上去还是一片“蓝海”的“减肥药”市场。 11月23日晚,智飞生物发布公告,拟支付现金收购重庆宸安生物制药有限公司100%股权,进军减肥药领域。今年上半年,公司代理产品收入占比超过90%。 二级市场上,目前,智飞生物的股价为66.12元/股,较2021年5月17日的股价下跌了56.80%,对应的市值,蒸发了2100亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2023-11-27/doc-imzvzirc4484887.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2023-11-27/doc-imzvzirc4484887.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-09-28","address":"重庆市江北区庆云路1号50层","stockEarnings":[{"period":"1week","weight":-0.1398},{"period":"1month","weight":-0.2335},{"period":"3month","weight":-0.2855},{"period":"6month","weight":-0.4337},{"period":"1year","weight":-0.3575},{"period":"ytd","weight":-0.43}],"companyName":"重庆智飞生物制品股份有限公司","boardCode":"AI0027","perCapita":"14579股","boardName":"医药制造业","registeredCapital":"239378万元","compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0613},{"period":"6month","weight":0.0235},{"period":"1year","weight":-0.06},{"period":"ytd","weight":0.0382}],"survey":" 重庆智飞生物制品股份有限公司是一家从事疫苗、生物制品的研发、生产和销售的公司;公司的主要产品包括预防流脑、宫颈癌、肺炎、轮状病毒等传染病的疫苗产品,也涵盖提供结核感染诊断、预防、治疗有效解决方案的药品。公司自成立以来,一贯注重研发与技术创新,通过十余年稳步增长的研发投入和持续深入的研发活动,形成了行业较领先的研发技术能力,并为公司可持续发展提供了技术根基。先后参与了科技部“863计划”,“现代医学技术”项目,科技部重大新药创制,国家新药创制重大专项等20余项国家级,省部级项目。","serverTime":1714187193445,"listedPrice":37.98,"stockholders":"97008人(较上一季度增加3.87%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"智飞生物,300122,智飞生物股票,智飞生物股票老虎,智飞生物股票老虎国际,智飞生物行情,智飞生物股票行情,智飞生物股价,智飞生物股市,智飞生物股票价格,智飞生物股票交易,智飞生物股票购买,智飞生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"智飞生物(300122)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供智飞生物(300122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}